CD8A and neoplasm: In addition to enhancing the functions of Tregs, NRP1 can also inhibit the immune memory generated by CD8+ T cells in the process of anti-tumor immunity, and anti-NRP1 treatment can improve the efficacy of anti-PD-1 immunotherapy (Leclerc et al., 2019).